|THPMP042||Performance Optimization of Ion Beam Therapy||proton, FEL, diagnostics, simulation||3537|
Funding: This project has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie SkłodowskaCurie grant agreement No 675265.
Proton beam therapy promises significant advantages over other forms of radiation therapy. However, to assure the best possible cancer care for patients further R&D into novel beam imaging and patient diagnostics, enhanced biological and physical models in Monte Carlo codes, as well as clinical facility design and optimization is required. Within the pan-European Optimization of Medical Accelerators (OMA) project collaborative research is being carried out between universities, research and clinical facilities, and industry in all of these areas. This contribution presents results from studies into low-intensity proton beam diagnostics, prompt gamma-based range verification in proton therapy, as well as prospects for a new proton irradiation facility for radiobiological measurements at an 18 MeV cyclotron within OMA. These results are then connected to the wider project aims of enhancing ion beam therapy. A summary of past and future events organised by the OMA consortium is also given.
|DOI •||reference for this paper ※ https://doi.org/10.18429/JACoW-IPAC2019-THPMP042|
|About •||paper received ※ 10 May 2019 paper accepted ※ 23 May 2019 issue date ※ 21 June 2019|
|Export •||reference for this paper using ※ BibTeX, ※ LaTeX, ※ Text/Word, ※ RIS, ※ EndNote (xml)|